Article Type
Editorial
Published
This editorial reviews the trial data for aducanumab in the treatment of Alzheimer’s disease and the controversies that its approval has generated.
Editorial
This editorial reviews the trial data for aducanumab in the treatment of Alzheimer’s disease and the controversies that its approval has generated.